American Research & Management Company’s DexCom DXCM Stock Holding History

American Research & Management Company’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$55K	Buy	687 +47	+7%	+$3.98K	0.02%	188
2022 Q2	$48K	Hold	640	–	–	0.01%	201
2022 Q1	$82K	Hold	640	–	–	0.02%	179
2021 Q4	$86K	Hold	640	–	–	0.02%	178
2021 Q3	$87K	Sell	640 -120	-16%	-$15.1K	0.02%	175
2021 Q2	$81K	Hold	760	–	–	0.02%	184
2021 Q1	$68K	Hold	760	–	–	0.02%	188
2020 Q4	$70K	Hold	760	–	–	0.02%	185
2020 Q3	$78K	Hold	760	–	–	0.02%	162
2020 Q2	$77K	Hold	760	–	–	0.02%	161
2020 Q1	$51K	Hold	760	–	–	0.02%	175
2019 Q4	$42K	Hold	760	–	–	0.01%	197
2019 Q3	$28K	Hold	760	–	–	0.01%	228
2019 Q2	$28K	Hold	760	–	–	0.01%	237
2019 Q1	$23K	Buy	760 +360	+90%	+$12.7K	0.01%	267
2018 Q4	$12K	Hold	400	–	–	﹤0.01%	266
2018 Q3	$14K	Hold	400	–	–	﹤0.01%	273
2018 Q2	$9K	Sell	400 -400	-50%	-$8.48K	﹤0.01%	271
2018 Q1	$15K	Hold	800	–	–	﹤0.01%	275
2017 Q4	$11K	Hold	800	–	–	﹤0.01%	295
2017 Q3	$10K	Hold	800	–	–	﹤0.01%	271
2017 Q2	$15K	Hold	800	–	–	﹤0.01%	238
2017 Q1	$17K	Hold	800	–	–	0.01%	226
2016 Q4	$12K	Hold	800	–	–	﹤0.01%	261
2016 Q3	$18K	Hold	800	–	–	0.01%	247
2016 Q2	$16K	Hold	800	–	–	0.01%	234
2016 Q1	$14K	Hold	800	–	–	0.01%	248
2015 Q4	$16K	Buy	+800	New	+$16.6K	0.01%	239

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

American Research & Management Company's DXCM Position: Q3 2022 in Review

American Research & Management Company increased its DexCom (DXCM) stake by 7.3% in Q3 2022, buying an estimated $3.98K and bringing the position to 687 shares worth $55K. The position accounts for 0.02% of the portfolio, ranked #188.

American Research & Management Company first reported a position in DXCM in Q4 2015 and has held it in 28 quarters since. The position peaked at $87K in Q3 2021. 795 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

American Research & Management Company held 687 shares of DexCom worth $55K as of Q3 2022.
American Research & Management Company bought 47 DexCom shares in Q3 2022, an estimated $3.98K.
DexCom made up 0.02% of American Research & Management Company's portfolio in Q3 2022, its #188 holding.
American Research & Management Company first reported a position in DexCom in Q4 2015 and has held it in 28 quarters since.
American Research & Management Company's DexCom position peaked at $87K in Q3 2021.
795 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.